Results 171 to 180 of about 12,986,553 (373)

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.

New England Journal of Medicine, 2016
Stuart J Connolly, T. Milling, J. Eikelboom, C. Michael, Gibson, J. Curnutte, A. Gold, M. Bronson, Genmin Lu, P. Conley, P. Verhamme, Jeannot Schmidt, S. Middeldorp, Alexander T Cohen, J. Beyer-Westendorf, P. Albaladéjo, J. López-Sendón, S. Goodman, J. Leeds, Brian L. Wiens, Deborah M Siegal, E. Zotova, Brandi Meeks, J. Nakamya, W. Lim, M. Crowther   +25 more
semanticscholar   +1 more source

Estimated impact of model‐guided venous thromboembolism prophylaxis versus real‐world practice

Journal of Hospital Medicine, EarlyView.
Abstract Background The American Society of Hematology (ASH) recommends assessing venous thromboembolism (VTE) and major bleeding risk to optimize pharmacological VTE prophylaxis for medical inpatients. However, the clinical utility of model‐guided approaches remains unknown.
Benjamin G Mittman, Michael B. Rothberg
wiley   +1 more source

Annexin 2/Factor Xa–Mediated Signal Transduction [PDF]

, 2008
Salvatore V. Pizzo
openalex   +1 more source

Comparison of Factor Iia Inhibitor and Factor Xa Inhibitors on Platelet Reactivity in Patients with Both Atrial Fibrillation and Coronary Artery Disease

, 2023
Kailiang Zheng, Willem L. Bor, Ashley Verburg, Errol W. Aarnink, Benjamin Mahmoodi, Hans Kelder, C. M. Hackeng, Jurriën M. ten Berg   +7 more
openalex   +1 more source

The Impact of Vision Problems on Households' Incomes: Evidence From the 2019 and 2022 Rounds of the Turkey Health Survey

Journal of International Development, EarlyView.
ABSTRACT Vision problems reduce individuals' quality of life, and they also reduce their productivity as workers and consequently decrease their incomes. Most vision problems can be corrected with properly fitted eyeglasses, but many people with vision problems do not have such eyeglasses.
Paul Glewwe, Hasan Gul, Aysit Tansel, Suzanne Wisniewski   +3 more
wiley   +1 more source

Management of heparin-induced thrombocytopenia with factor xa inhibitors: A systematic review

Thrombosis Update
Heparin-induced thrombocytopenia (HIT) is a rare but severe prothrombotic disorder that develops in patients exposed to heparin products. Diagnosis is associated with significant morbidity and mortality.
Colton Jones, Abiodun Idowu, Elvis Obomanu, Raymond Smith, Karecia Byfield, Avinash Ramkissoon, Kevin Bryan Lo, Ryan Mayo   +7 more
doaj   +1 more source

Measurement of Anti-Factor Xa Activity in Patients on Apixaban for Non-Valvular Atrial Fibrillation

, 2015
Hiroyuki Osanai, Masayoshi Ajioka, Tomohiro Masutomi, Tasuku Kuwayama, Sota Ishihama, Yusuke Sakamato, Naoya Otaka, Teruhiro Sakaguchi, Yosuke Inoue, Takahiro Kanbara, Yoshihito Nakashima, Hiroshi Asano, Kazuyoshi Sakai   +12 more
openalex   +2 more sources

324. Factor-Xa-Reactive Antibodies in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome Have Differential Effects on Coagulation Assays [PDF]

, 2014
Bahar Artım-Esen, Charis Pericleous, Ian Mackie, David Isenberg, Anisur Rahman, Yiannis Ioannou, Ian Giles   +6 more
openalex   +1 more source

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt, Christa M. Cobbaert, L. Renee Ruhaak   +2 more
wiley   +1 more source

Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors

Clinical Pharmacology: Advances and Applications, 2015
Pontus B Persson Institute of Vegetative Physiology, Berlin, GermanyApixaban and rivaroxaban are oral factor Xa inhibitors. In a recent issue of Clinical Pharmacology: Advances and Applications, Frost et al compare apixaban (2.5 mg, twice daily) to ...
Persson PB
doaj